Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression

WNT5A-mediated  -catenin-independent signalling is a novel regulator of cancer cell metabolism

(2013) V. Sherwood et al.   CARCINOGENESIS

Wnt5a Directs Polarized Calcium Gradients by Recruiting Cortical Endoplasmic Reticulum to the Cell Trailing Edge

(2013) Eric S. Witze et al.   DEVELOPMENTAL CELL

Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways

(2013) Bei Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells

(2013) Chandra Prakash Prasad et al.   Molecular Oncology

Wnt5a Inhibits Human Monocyte-Derived Myeloid Dendritic Cell Generation

(2013) C. Bergenfelz et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A Wnt-er Migration: The Confusing Role of  -Catenin in Melanoma Metastasis

(2013) M. R. Webster et al.   Science Signaling

The Small GTPase ARF6 Stimulates  -Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis

(2013) A. H. Grossmann et al.   Science Signaling

Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2

(2013) M. P. O'Connell et al.   Cancer Discovery

Differential Regulation of the Mouse and Human Wnt5a Alternative Promoters A and B

(2012) Karen S. Katula et al.   DNA AND CELL BIOLOGY

Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma

(2012) Lise Hoejberg et al.   MELANOMA RESEARCH

Wnt5a: its signalling, functions and implication in diseases

(2011) A. Kikuchi et al.   Acta Physiologica

ROCK and JAK1 Signaling Cooperate to Control Actomyosin Contractility in Tumor Cells and Stroma

(2011) Victoria Sanz-Moreno et al.   CANCER CELL

Interleukin-6 signalling: More than Jaks and STATs

(2011) René Eulenfeld et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

STAT3 SIGNALING: Anticancer Strategies and Challenges

(2011) P. A. Johnston et al.   MOLECULAR INTERVENTIONS

Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy

(2011) X. WANG et al.   NEOPLASMA

The role of mitogen- and stress-activated protein kinase pathways in melanoma

(2011) Pablo Lopez-Bergami   Pigment Cell & Melanoma Research

Striking the target in Wnt-y conditions: Intervening in Wnt signaling during cancer progression

(2010) Tura C. Camilli et al.   BIOCHEMICAL PHARMACOLOGY

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma

(2009) M P O’Connell et al.   ONCOGENE

Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt

(2009) Michael P. O’Connell et al.   Pigment Cell & Melanoma Research

CD47 Regulates Collagen I-Induced Cyclooxygenase-2 Expression and Intestinal Epithelial Cell Migration

(2009) Oliver Jay Broom et al.   PLoS One

A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion

(2009) V. Jenei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

(2008) S. K. Dissanayake et al.   CANCER RESEARCH

WNT5A Exhibits Tumor-Suppressive Activity through Antagonizing the Wnt/ -Catenin Signaling, and Is Frequently Methylated in Colorectal Cancer

(2008) J. Ying et al.   CLINICAL CANCER RESEARCH

WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome

(2008) P. D. Da Forno et al.   CLINICAL CANCER RESEARCH